[Myositis: From classification to diagnosis].
Myosites : de la classification au diagnostic.
Anticorps spécifique des myosites
Antisynthetase
Antisynthétase
Dermatomyosite
Dermatomyositis
Inflammatory myopathy
Myopathie inflammatoire
Myosite
Myositis
Myositis-specific antibodies
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
10
08
2020
revised:
26
09
2020
accepted:
18
10
2020
pubmed:
30
11
2020
medline:
25
11
2021
entrez:
29
11
2020
Statut:
ppublish
Résumé
Idiopathic inflammatory myopathies, or IIM, are a group of acquired diseases that affect the muscle to a certain extent, and may also affect other organs. They include dermatomyositis, which can affect the muscle eventualy, with a typical skin rash; inclusion body myositis, with a purely muscular expression resulting in a slow progressive deficit; and the former group of "polymyositis", a misnomer that actually includes other categories of IIM, such as immune-mediated necrotizing myopathies, with a severe muscle involvement often presents from the onset of the disease; antisynthetase syndrome, which combines muscle damage, joint involvement and a potentially life-threatening lung disease; and overlapping myositis, which combines muscle damage with other organs involvement connected to another autoimmune disease. The diagnosis of IIM is based on rigorous clinical examination and interrogation, electromyographic data and immunological testing for myositis specific antibodies. This antibody dosage must be extended or repeated if necessary to classify correctly the muscle disease under investigation, as the available tests may not perform well enough. Muscle biopsy, although very informative, is not anymore systematically recommended when the clinic and the antibodies are typical. However, some forms of IIM are sometimes difficult to classify; in these cases, muscle biopsy plays a crucial role in the precise etiological diagnosis.
Identifiants
pubmed: 33248855
pii: S0248-8663(20)30774-8
doi: 10.1016/j.revmed.2020.10.379
pii:
doi:
Substances chimiques
Autoantibodies
0
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
392-400Informations de copyright
Copyright © 2020 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.